Boehringer Ingelheim Venture Fund key facts
- Boehringer Ingelheim Venture Fund is a other based in Ingelheim am Rhein, Germany with 21 tracked portfolio companies.
- Notable positions include AgomAb, Rgenta Therapeutics, Wellth (Healthcare Technology Systems).
About Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is a direct investment firm based in Ingelheim am Rhein, Germany. Established in 2010, it is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science that offers the potential to provide a significant benefit for patients. It operates as a subsidiary under Boehringer Ingelheim. The assets of the firm are managed by its executive management team.
Boehringer Ingelheim Venture Fund portfolio at a glance
21 portfolio companies are on record for Boehringer Ingelheim Venture Fund, including AgomAb, Rgenta Therapeutics and Wellth (Healthcare Technology Systems).
14 of the 21 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 21 recorded positions
- ·Watchlist + alerts for Boehringer Ingelheim Venture Fund's activity
Portfolio
21 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| AgomAb | Drug Discovery | ▮ | ▮ | ▮ |
| Rgenta Therapeutics | — | ▮ | ▮ | ▮ |
| Wellth (Healthcare Technology Systems) | — | ▮ | ▮ | ▮ |
+ 18 more companies · all 21, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Boehringer Ingelheim Venture Fund
- What companies does Boehringer Ingelheim Venture Fund invest in?
- Boehringer Ingelheim Venture Fund has 21 recorded portfolio companies, including AgomAb, Rgenta Therapeutics, Wellth (Healthcare Technology Systems).
- What is Boehringer Ingelheim Venture Fund's AUM?
- Boehringer Ingelheim Venture Fund manages approximately $405 in assets.